• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

器官移植术后患者的感染——叙述性概述

Infection in Patients after Organ Transplantation-A Narrative Overview.

作者信息

Dudzicz-Gojowy Sylwia, Więcek Andrzej, Adamczak Marcin

机构信息

Department of Nephrology, Transplantation and Internal Medicine, Medical University of Silesia, Francuska 20-24, 40-027 Katowice, Poland.

出版信息

J Clin Med. 2022 Jul 27;11(15):4365. doi: 10.3390/jcm11154365.

DOI:10.3390/jcm11154365
PMID:35955980
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9368854/
Abstract

infection (CDI) is one of the most common causes of antibiotic-associated diarrhea. The pathogenesis of this infection participates in the unstable colonization of the intestines with the physiological microbiota. Solid-organ-transplant (SOT) patients and patients after hematopoietic stem cell transplantation are more prone to CDI compared to the general population. The main CDI risk factors in these patients are immunosuppressive therapy and frequent antibiotic use leading to dysbiosis. The current review article provides information about the risk factors, incidence and course of CDI in patients after liver, kidney, heart and lung transplantation and hematopoietic stem cell transplantation.

摘要

艰难梭菌感染(CDI)是抗生素相关性腹泻最常见的病因之一。这种感染的发病机制涉及肠道内生理微生物群的不稳定定植。与普通人群相比,实体器官移植(SOT)患者和造血干细胞移植后的患者更容易发生CDI。这些患者发生CDI的主要危险因素是免疫抑制治疗和频繁使用抗生素导致的生态失调。本综述文章提供了有关肝、肾、心、肺移植及造血干细胞移植后患者发生CDI的危险因素、发病率和病程的信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b6/9368854/9fda8929a0a1/jcm-11-04365-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b6/9368854/9fda8929a0a1/jcm-11-04365-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49b6/9368854/9fda8929a0a1/jcm-11-04365-g001.jpg

相似文献

1
Infection in Patients after Organ Transplantation-A Narrative Overview.器官移植术后患者的感染——叙述性概述
J Clin Med. 2022 Jul 27;11(15):4365. doi: 10.3390/jcm11154365.
2
Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients.异基因造血干细胞和实体器官移植受者中艰难梭菌感染的早期特征、风险和结局。
Transpl Infect Dis. 2022 Feb;24(1):e13720. doi: 10.1111/tid.13720. Epub 2021 Sep 25.
3
Clostridioides difficile infection and recurrence among 2622 solid organ transplant recipients.2622例实体器官移植受者中的艰难梭菌感染及复发情况
Transpl Infect Dis. 2019 Dec;21(6):e13184. doi: 10.1111/tid.13184. Epub 2019 Oct 11.
4
Toxigenic colonization as a risk factor for development of infection in solid-organ transplant patients.产毒定植作为实体器官移植患者感染发展的危险因素。
Infect Control Hosp Epidemiol. 2021 Mar;42(3):287-291. doi: 10.1017/ice.2020.431. Epub 2020 Sep 16.
5
Risk Factors for Clostridioides Difficile Diarrhea In Solid Organ Transplantation Recipients.实体器官移植受者艰难梭菌腹泻的危险因素。
Transplant Proc. 2021 Dec;53(10):2826-2832. doi: 10.1016/j.transproceed.2021.09.047. Epub 2021 Nov 10.
6
Incidence Rates and Risk Factors of Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients.实体器官和造血干细胞移植受者感染的发病率及危险因素
Open Forum Infect Dis. 2019 Feb 19;6(4):ofz086. doi: 10.1093/ofid/ofz086. eCollection 2019 Apr.
7
Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study.实体器官和造血干细胞移植受者艰难梭菌感染:一项前瞻性多国研究。
Transpl Infect Dis. 2022 Feb;24(1):e13770. doi: 10.1111/tid.13770. Epub 2021 Dec 13.
8
Risk factors for Clostridioides (Clostridium) difficile infection following solid organ transplantation in children.儿童实体器官移植后艰难梭菌感染的危险因素。
Transpl Infect Dis. 2019 Oct;21(5):e13149. doi: 10.1111/tid.13149. Epub 2019 Aug 5.
9
Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplantation Community of Practice.实体器官移植受者艰难梭菌(以前称为梭状芽孢杆菌)感染(CDI)的管理:美国移植学会实践社区指南。
Clin Transplant. 2019 Sep;33(9):e13564. doi: 10.1111/ctr.13564. Epub 2019 Jun 20.
10
Infection in Kidney Transplant Recipients.肾移植受者的感染
Pathogens. 2024 Feb 4;13(2):140. doi: 10.3390/pathogens13020140.

引用本文的文献

1
Infection in Kidney Transplant Recipients.肾移植受者的感染
Pathogens. 2024 Feb 4;13(2):140. doi: 10.3390/pathogens13020140.
2
How we treat diarrhea in pediatric transplant patients: a brief review.我们如何治疗小儿移植患者的腹泻:简要综述
Front Pediatr. 2023 Dec 8;11:1287445. doi: 10.3389/fped.2023.1287445. eCollection 2023.

本文引用的文献

1
SER-109, an Oral Microbiome Therapy for Recurrent Infection.SER-109,一种用于复发性感染的口腔微生物组疗法。
N Engl J Med. 2022 Jan 20;386(3):220-229. doi: 10.1056/NEJMoa2106516.
2
Roles of the intestinal microbiota and microbial metabolites in acute GVHD.肠道微生物群和微生物代谢产物在急性移植物抗宿主病中的作用。
Exp Hematol Oncol. 2021 Oct 27;10(1):49. doi: 10.1186/s40164-021-00240-3.
3
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.
欧洲临床微生物学和传染病学会:成人艰难梭菌感染治疗指南的 2021 年更新。
Clin Microbiol Infect. 2021 Dec;27 Suppl 2:S1-S21. doi: 10.1016/j.cmi.2021.09.038. Epub 2021 Oct 20.
4
Clostridioides difficile Infection and Risk of Acute Graft-versus-Host Disease among Allogeneic Hematopoietic Stem Cell Transplantation Recipients.艰难梭菌感染与异基因造血干细胞移植受者急性移植物抗宿主病的风险。
Transplant Cell Ther. 2021 Feb;27(2):176.e1-176.e8. doi: 10.1016/j.jtct.2020.10.009. Epub 2020 Dec 11.
5
Risk Factors and Outcome of Infection after Hematopoietic Stem Cell Transplantation.造血干细胞移植后感染的危险因素及结局
J Clin Med. 2020 Nov 16;9(11):3673. doi: 10.3390/jcm9113673.
6
The gut microbiome in solid organ transplantation.实体器官移植中的肠道微生物组。
Pediatr Transplant. 2020 Nov;24(7):e13866. doi: 10.1111/petr.13866. Epub 2020 Sep 30.
7
The burden of Clostridioides difficile infection in patients with history of liver transplant and during index admission.肝移植病史患者和入院期间艰难梭菌感染的负担。
Eur J Gastroenterol Hepatol. 2021 Jun 1;33(6):894-898. doi: 10.1097/MEG.0000000000001812.
8
Characteristics and Dysbiosis of the Gut Microbiome in Renal Transplant Recipients.肾移植受者肠道微生物群的特征与失调
J Clin Med. 2020 Feb 1;9(2):386. doi: 10.3390/jcm9020386.
9
Clostridium Difficile infections in patients with AML or MDS undergoing allogeneic hematopoietic stem cell transplantation identify high risk for adverse outcome.接受异基因造血干细胞移植的急性髓系白血病或骨髓增生异常综合征患者发生艰难梭菌感染表明不良结局风险高。
Bone Marrow Transplant. 2020 Feb;55(2):367-375. doi: 10.1038/s41409-019-0678-y. Epub 2019 Sep 18.
10
: diagnosis and treatments.诊断和治疗。
BMJ. 2019 Aug 20;366:l4609. doi: 10.1136/bmj.l4609.